
    
      PROTOCOL OUTLINE: This is a randomized, placebo controlled, double blind, multicenter study.
      Patients are stratified according to prematurity or surgical group.

      Patients are randomized to receive either placebo or sincalide IV over 10 to 15 minutes every
      12 hours until a total of 8 weeks of therapy is administered or greater than 50% of their
      nutrition is enteral.

      Patients are followed for a maximum of 2 years.

      Completion date provided represents the completion date of the grant per OOPD records
    
  